Eyenuk

United States
Pinetop-Lakeside, Arizona, United States, 91367

Company profile

Eyenuk company profile

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance. The company's first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for the autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life-and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. The company was founded in 2010 and is based in Los Angeles, California.

Business identity

Contact email
[email protected]
Phone number
+1 818 835 3585
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
91367
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
12
Total equity funding
$38.5M
Last funding
Series A / $26M / 2022-10-17
Last equity funding
Series A / $26M
Investors
6
Lead investors
1
Founders
1
Articles
61

Founders and investors

Founders

Kaushal Solanki

Lead investors

AXA Investment Managers

Investors

AXA Investment ManagersGlobal Health Investment Fund (GHIF)Kendall Capital PartnersKOFA HealthcareT&W Medical